- £218.75bn
- £236.77bn
- $54.07bn
- 78
- 14
- 98
- 73
RCS - Halix B.V. - HALIX Signs Agreement With AstraZeneca
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Crestor to be divested to Grünenthal in Europe
AnnouncementREG - AstraZeneca PLC - Forxiga approved in Japan for heart failure
AnnouncementREG - AstraZeneca PLC - AZD1222 vaccine effective against COVID-19
AnnouncementREG - AstraZeneca PLC - Imfinzi new dosing approved in the US
AnnouncementREG - Jupiter Asset Mgmnt - Portfolio Update
AnnouncementREG - AstraZeneca PLC - Tezepelumab Phase III trial met primary endpoint
AnnouncementREG - AstraZeneca PLC - Calquence approved in the EU for CLL
AnnouncementREG - AstraZeneca PLC - Brilinta approved in the US in stroke
AnnouncementREG - AstraZeneca PLC - Lynparza approved in the EU for wider ovarian use
AnnouncementREG - AstraZeneca PLC - Lynparza approved in the EU for prostate cancer
AnnouncementREG - AstraZeneca PLC - Forxiga approved in the EU for heart failure
AnnouncementREG - AstraZeneca PLC - AZN: Year-to-date and Q3 2020 results
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Atacand to be divested in more than 70 countries
AnnouncementREG - AstraZeneca PLC - Directorate Change
AnnouncementREG - AstraZeneca PLC - Enhertu US Priority Review in gastric cancer
Announcement